Showing results (1841-1850 of 2,051) with videos related to
Sort By:
Pageof 206
Clinical Pharmacology in Drug Development|September 6, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)Deven V Parmar, Kevinkumar A Kansagra, Taufik Momin, et al.Blood Vessels, Thrombosis & Hemostasis|May 21, 2026
A multicenter analysis revisiting the PLASMIC score: performance limitations and the impact of age, MCV, and LDHRishabh Singh, Ashley Khouri, Ho Jun Lee, et al.Microbial Pathogenesis|June 20, 2023
RIG-I expression pattern and cytokine profile in indigenous ducks infected with duck plague virusPrasanta Chabukdhara, Dhruba Jyoti Kalita, Shantanu Tamuly, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|January 10, 2015
Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injuryShenika V Poindexter, Vishruth K Reddy, Mukul K Mittal, et al.Luminescence : the Journal of Biological and Chemical Luminescence|June 18, 2026
A Mechanistic and Analytical Study of a Magnetically Separable Fe<sub>3</sub>O<sub>4</sub>/g-C<sub>3</sub>N<sub>4</sub>/SWCNT Photocatalyst: A Kinetic, GC-MS Degradation Pathways and AAS Leachate AnalysisSyed Kashif Ali, Mohd Imran, Abdullah Ali Alamri, et al.Ultrasonics Sonochemistry|March 8, 2025
Enhancing starch properties through dual modification: Ultrasonication and acetic acid treatment of non-conventional starchesLikhitha Yadav Prakruthi, Hari Krishnan, Tamma Medha, et al.Brain Research|July 29, 2024
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's diseaseAbhijit Chatterjee, Jogeswar Mohapatra, Manoranjan Sharma, et al.Journal of Medicinal Chemistry|November 6, 2007
Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology modelBrijesh Kumar Srivastava, Amit Joharapurkar, Saurin Raval, et al.American Heart Journal|February 16, 2018
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trialAtul Verma, Andrew C T Ha, Paulus Kirchhof, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effectBrijesh Kumar Srivastava, Rina Soni, Jayendra Z Patel, et al.Pageof 206